{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:07:04Z","timestamp":1790352424469,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003995","name":"Anhui Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2408085MH204"],"award-info":[{"award-number":["2408085MH204"]}],"id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82502430"],"award-info":[{"award-number":["82502430"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.bioorg.2026.109890","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T23:14:01Z","timestamp":1776467641000},"page":"109890","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Development and preclinical evaluation of NYM074 as a novel Theranostic ligand targeting carbonic anhydrase IX in renal cell carcinoma"],"prefix":"10.1016","volume":"176","author":[{"given":"Shun","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongrui","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijia","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialun","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyang","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng-Fei","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuiping","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bioorg.2026.109890_bb0005","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bioorg.2026.109890_bb0010","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.6004\/jnccn.2020.0043","article-title":"NCCN guidelines insights: kidney cancer, version 1.2021","volume":"18","author":"Motzer","year":"2020","journal-title":"J. Natl. Compr. Canc. Netw."},{"issue":"11S","key":"10.1016\/j.bioorg.2026.109890_bb0015","first-page":"S415","article-title":"ACR appropriateness criteria(R) indeterminate renal mass","volume":"17","author":"Urologic","year":"2020","journal-title":"J. Am. Coll. Radiol."},{"issue":"12","key":"10.1016\/j.bioorg.2026.109890_bb0020","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1007\/s00345-018-2342-3","article-title":"Imaging for the diagnosis and response assessment of renal tumours","volume":"36","author":"Rossi","year":"2018","journal-title":"World J. Urol."},{"key":"10.1016\/j.bioorg.2026.109890_bb0025","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.5c03078","article-title":"Synthesis and preclinical evaluation of 99mTc-Labeled benzenesulfonamides for SPECT imaging of carbonic anhydrase IX expression","author":"Ding","year":"2025","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2026.109890_bb0030","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0002-9440(10)64048-5","article-title":"Expression of the hypoxia-inducible and tumor-associated carbonic anhydrases in ductal carcinoma in situ of the breast","volume":"158","author":"Wykoff","year":"2001","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109890_bb0035","article-title":"HIF-1\u03b1 and HIF-2\u03b1 differently regulate tumour development and inflammation of clear cell renal cell carcinoma in mice. Nature","volume":"11","author":"Hoefflin","year":"2020","journal-title":"Communications"},{"issue":"4","key":"10.1016\/j.bioorg.2026.109890_bb0040","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.eururo.2015.08.007","article-title":"Hypoxia, hypoxia-inducible transcription factors, and renal cancer","volume":"69","author":"Sch\u00f6del","year":"2016","journal-title":"Eur. Urol."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109890_bb0045","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/metabo8010019","article-title":"Carbonic anhydrases: role in pH control and cancer","volume":"8","author":"Mboge","year":"2018","journal-title":"Metabolites"},{"issue":"2","key":"10.1016\/j.bioorg.2026.109890_bb0050","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1200\/JCO.2011.41.2445","article-title":"Positron emission tomography\/computed tomography identification of clear cell renal cell carcinoma: results from the REDECT trial","volume":"31","author":"Divgi","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.bioorg.2026.109890_bb0055","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/14737140.2025.2454483","article-title":"Girentuximab imaging in renal cancer: diamond in the rough or just ZIRCON?","volume":"25","author":"Filippi","year":"2025","journal-title":"Expert Rev. Anticancer Ther."},{"issue":"10","key":"10.1016\/j.bioorg.2026.109890_bb0060","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1007\/s00259-023-06248-7","article-title":"Preclinical and pilot clinical evaluation of a small-molecule carbonic anhydrase IX targeting PET tracer in clear cell renal cell carcinoma","volume":"50","author":"Zhu","year":"2023","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"8","key":"10.1016\/j.bioorg.2026.109890_bb0065","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1007\/s00259-024-06672-3","article-title":"ImmunoPET\/CT imaging of clear cell renal cell carcinoma with [(18)F]RCCB6: a first-in-human study","volume":"51","author":"Wu","year":"2024","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"7","key":"10.1016\/j.bioorg.2026.109890_bb0070","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1021\/acs.molpharmaceut.4c00104","article-title":"A CAIX dual-targeting small-molecule probe for noninvasive imaging of ccRCC","volume":"21","author":"He","year":"2024","journal-title":"Mol. Pharm."},{"issue":"31","key":"10.1016\/j.bioorg.2026.109890_bb0075","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1200\/JCO.2012.42.4887","article-title":"Advances in Immuno\u2013Positron Emission Tomography: Antibodies for Molecular Imaging in Oncology","volume":"30","author":"Knowles","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"13","key":"10.1016\/j.bioorg.2026.109890_bb0080","doi-asserted-by":"crossref","first-page":"6431","DOI":"10.1021\/acs.jmedchem.6b00623","article-title":"Synthesis and in vivo biological evaluation of 68Ga-Labeled carbonic anhydrase IX targeting small molecules for positron emission tomography","volume":"59","author":"Sneddon","year":"2016","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2026.109890_bb0085","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1080\/13543784.2018.1548608","article-title":"Carbonic anhydrase inhibitors as emerging agents for the treatment and imaging of hypoxic tumors","volume":"27","author":"Supuran","year":"2018","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"10","key":"10.1016\/j.bioorg.2026.109890_bb0090","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1021\/acs.molpharmaceut.2c00034","article-title":"Molecular imaging of renal cell carcinoma in precision medicine","volume":"19","author":"Wu","year":"2022","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bioorg.2026.109890_bb0095","first-page":"766","article-title":"Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy","volume":"63","author":"Bui","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2026.109890_bb0100","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3389\/fcell.2016.00027","article-title":"Overcoming hypoxia-mediated tumor progression: combinatorial approaches targeting pH regulation, angiogenesis and immune dysfunction","volume":"4","author":"McDonald","year":"2016","journal-title":"Front. Cell Dev. Biol."},{"issue":"12","key":"10.1016\/j.bioorg.2026.109890_bb0105","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1158\/1535-7163.MCT-16-0283","article-title":"Acetazolamide serves as selective delivery vehicle for dipeptide-linked drugs to renal cell carcinoma","volume":"15","author":"Cazzamalli","year":"2016","journal-title":"Mol. Cancer Ther."},{"issue":"17","key":"10.1016\/j.bioorg.2026.109890_bb0110","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.7150\/thno.21848","article-title":"Past, present, and future: development of theranostic agents targeting carbonic anhydrase IX","volume":"7","author":"Lau","year":"2017","journal-title":"Theranostics"},{"issue":"10","key":"10.1016\/j.bioorg.2026.109890_bb0115","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S1470-2045(24)00402-9","article-title":"[89Zr]Zr-girentuximab for PET\u2013CT imaging of clear-cell renal cell carcinoma: a prospective, open-label, multicentre, phase 3 trial","volume":"25","author":"Shuch","year":"2024","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bioorg.2026.109890_bb0120","first-page":"68 (4)","article-title":"Synthesis, Preclinical Characterizations and Imaging Studies of [<sup>18<\/sup>F]AlF-Labeled NY104, a CAIX-Targeting Diagnostic Agent","author":"Huang","year":"2025","journal-title":"J. Label. Compd. Radiopharm."},{"issue":"4","key":"10.1016\/j.bioorg.2026.109890_bb0125","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1007\/s00259-024-07007-y","article-title":"Evaluation of the safety, biodistribution, dosimetry of [18F]AlF-NYM005 and initial experience in clear cell renal cell carcinoma: an interim analysis of a prospective trial","volume":"52","author":"Yang","year":"2024","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"5","key":"10.1016\/j.bioorg.2026.109890_bb0130","doi-asserted-by":"crossref","first-page":"740","DOI":"10.2967\/jnumed.123.267175","article-title":"First-in-human safety, imaging, and dosimetry of a carbonic anhydrase IX\u2013targeting peptide, [<sup>68<\/sup>ga]ga-DPI-4452, in patients with clear cell renal cell carcinoma","volume":"65","author":"Hofman","year":"2024","journal-title":"J. Nucl. Med."},{"issue":"5","key":"10.1016\/j.bioorg.2026.109890_bb0135","doi-asserted-by":"crossref","first-page":"761","DOI":"10.2967\/jnumed.123.266309","article-title":"Preclinical characterization of DPI-4452: a<sup>68<\/sup>ga\/<sup>177<\/sup>Lu theranostic ligand for carbonic anhydrase IX","volume":"65","author":"Massi\u00e8re","year":"2024","journal-title":"J. Nucl. Med."},{"issue":"13","key":"10.1016\/j.bioorg.2026.109890_bb0140","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1007\/s00259-024-06801-y","article-title":"Diagnostic efficacy of [(68)ga]ga-NY104 PET\/CT to identify clear cell renal cell carcinoma","volume":"51","author":"Zhu","year":"2024","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"12","key":"10.1016\/j.bioorg.2026.109890_bb0145","first-page":"1884","article-title":"Value of [(68)ga]ga-NYM046 PET\/CT, in comparison with (18)F-FDG PET\/CT, for diagnosis of clear cell renal cell carcinoma","volume":"65","author":"Lou","year":"2024","journal-title":"J. Nucl. Med."},{"issue":"6","key":"10.1016\/j.bioorg.2026.109890_bb0150","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1309\/AJCPPPR57HNJMSLZ","article-title":"Carbonic anhydrase IX expression in renal neoplasms","volume":"134","author":"Genega","year":"2010","journal-title":"Am. J. Clin. Pathol."},{"issue":"22","key":"10.1016\/j.bioorg.2026.109890_bb0155","doi-asserted-by":"crossref","first-page":"9435","DOI":"10.1021\/jm501003k","article-title":"Discovery and characterization of novel selective inhibitors of carbonic anhydrase IX","volume":"57","author":"Dudutien\u0117","year":"2014","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2026.109890_bb0160","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/nchem.2158","article-title":"Dual-display of small molecules enables the discovery of ligand pairs and facilitates affinity maturation","volume":"7","author":"Wichert","year":"2015","journal-title":"Nat. Chem."},{"key":"10.1016\/j.bioorg.2026.109890_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2025.107190","article-title":"PD-L1 downregulation by carbonic anhydrase IX immunotherapy prompts immune checkpoint blockade in renal cell carcinoma","volume":"213","author":"Pivetta","year":"2025","journal-title":"Eur. J. Pharm. Sci."},{"issue":"12","key":"10.1016\/j.bioorg.2026.109890_bb0170","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrclinonc.2012.171","article-title":"Imaging hypoxia to improve radiotherapy outcome","volume":"9","author":"Horsman","year":"2012","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.bioorg.2026.109890_bb0175","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1038\/s41591-020-1093-z","article-title":"Targeting the HIF2\u2013VEGF axis in renal cell carcinoma","volume":"26","author":"Choueiri","year":"2020","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109890_bb0180","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eururo.2010.03.015","article-title":"Carbonic anhydrase IX in renal cell carcinoma: implications for prognosis, diagnosis, and therapy","volume":"58","author":"Stillebroer","year":"2010","journal-title":"Eur. Urol."},{"key":"10.1016\/j.bioorg.2026.109890_bb0185","doi-asserted-by":"crossref","DOI":"10.1177\/17588359251317846","article-title":"Belzutifan for the treatment of renal cell carcinoma","volume":"17","author":"Wu","year":"2025","journal-title":"Ther. Adv. Med. Oncol."},{"issue":"4","key":"10.1016\/j.bioorg.2026.109890_bb0190","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s43018-025-00942-1","article-title":"Biomarker-informed care for patients with renal cell carcinoma","volume":"6","author":"McKinnon","year":"2025","journal-title":"Nat. Cancer"},{"issue":"1","key":"10.1016\/j.bioorg.2026.109890_bb0195","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12943-024-02059-y","article-title":"PD1\/PD-L1 blockade in clear cell renal cell carcinoma: mechanistic insights, clinical efficacy, and future perspectives","volume":"23","author":"Zhu","year":"2024","journal-title":"Mol. Cancer"},{"issue":"6","key":"10.1016\/j.bioorg.2026.109890_bb0200","doi-asserted-by":"crossref","DOI":"10.1002\/cnr2.2116","article-title":"Diagnostic, predictive and prognostic molecular biomarkers in clear cell renal cell carcinoma: A retrospective study","volume":"7","author":"Deng","year":"2024","journal-title":"Cancer Reports"},{"issue":"16_suppl","key":"10.1016\/j.bioorg.2026.109890_bb0205","doi-asserted-by":"crossref","first-page":"4506","DOI":"10.1200\/JCO.2024.42.16_suppl.4506","volume":"42","author":"Albiges","year":"2024","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.bioorg.2026.109890_bb0210","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.2967\/jnumed.117.204651","article-title":"\u0391-emitters for radiotherapy: from basic radiochemistry to clinical studies\u2014part 2","volume":"59","author":"Poty","year":"2018","journal-title":"J. Nucl. Med."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826004268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826004268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T01:48:50Z","timestamp":1778723330000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826004268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":42,"alternative-id":["S0045206826004268"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109890","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and preclinical evaluation of NYM074 as a novel Theranostic ligand targeting carbonic anhydrase IX in renal cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109890","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109890"}}